Tuberculosis Research Today is a free monthly online journal that collates and summarizes the latest research about Tuberculosis, including details on symptoms, causes, treatment, pulmonary, mycobacterium.

Volume 4 (2007), Issue 10 (October)

1. Endovascular treatment of a tuberculous infected aneurysm of the descending thoracic aorta: a word of caution.
   J Vasc Surg, 46(4): 786-8. [Abstract] [Full-text]
2. Immune function in young children with previous pulmonary or miliary/meningeal tuberculosis and impact of BCG vaccination.
   Pediatrics, 120(4): e912-21. [Abstract] [Full-text]
3. Cross-talk between CD31 and the signaling lymphocytic activation molecule-associated protein during interferon- gamma production against Mycobacterium tuberculosis.
   J Infect Dis, 196(9): 1369-78. [Abstract] [Full-text]
4. Mast cells modulate pulmonary acute inflammation and host defense in a murine model of tuberculosis.
   J Infect Dis, 196(9): 1361-8. [Abstract] [Full-text]
5. Granulocyte chemotactic properties of M. tuberculosis versus M. bovis-infected bovine alveolar macrophages.
   Mol Immunol, 45(3): 740-9. [Abstract] [Full-text]
6. Interleukin-12p40 overexpression promotes interleukin-12p70 and interleukin-23 formation but does not affect bacille Calmette-Guérin and Mycobacterium tuberculosis clearance.
   Immunology, 122(3): 350-61. [Abstract] [Full-text]
7. Tuberculosis susceptibility of diabetic mice.
   Am J Respir Cell Mol Biol, 37(5): 518-24. [Abstract] [Full-text]
8. Immunodominant tuberculosis CD8 antigens preferentially restricted by HLA-B.
   PLoS Pathog, 3(9): 1240-9. [Abstract] [Full-text]
9. Effects of DNA- and Mycobacterium bovis BCG-based delivery of the Flt3 ligand on protective immunity to Mycobacterium tuberculosis.
   Infect Immun, 75(11): 5368-75. [Abstract] [Full-text]
10. Nucleotide-binding oligomerization domain protein 2-deficient mice control infection with Mycobacterium tuberculosis.
    Infect Immun, 75(11): 5127-34. [Abstract] [Full-text]
11. Mycobacterium tuberculosis-induced gamma interferon production by natural killer cells requires cross talk with antigen-presenting cells involving Toll-like receptors 2 and 4 and the mannose receptor in tuberculous pleurisy.
    Infect Immun, 75(11): 5325-37. [Abstract] [Full-text]
12. Impaired expression of perforin and granulysin in CD8+ T cells at the site of infection in human chronic pulmonary tuberculosis.
    Infect Immun, 75(11): 5210-22. [Abstract] [Full-text]
13. Information systems for patient follow-up and chronic management of HIV and tuberculosis: a life-saving technology in resource-poor areas.
    J Med Internet Res, 9(4): e29. [Abstract] [Full-text]
14. Advances in the treatment of tuberculosis.
    Clin Pharmacol Ther, 82(5): 595-600. [Abstract] [Full-text]
15. XCL1 (lymphotactin) chemokine produced by activated CD8 T cells during the chronic stage of infection with Mycobacterium tuberculosis negatively affects production of IFN-gamma by CD4 T cells and participates in granuloma stability.
    J Leukoc Biol, 82(5): 1221-9. [Abstract] [Full-text]
16. Primary health care nurses implement and evaluate a community outreach approach to health care in the South African agricultural sector.
    Int Nurs Rev, 54(4): 383-90. [Abstract] [Full-text]
17. How a different look at latency can help to develop novel diagnostics and vaccines against tuberculosis.
    Expert Opin Biol Ther, 7(11): 1665-77. [Abstract] [Full-text]
18. Prevention of nosocomial transmission of extensively drug-resistant tuberculosis in rural South African district hospitals: an epidemiological modelling study.
    Lancet, 370(9597): 1500-7. [Abstract] [Full-text]
19. Tuberculosis in adult patients with sickle cell disease.
    J Infect, 55(5): 439-44. [Abstract] [Full-text]
20. Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis.
    Clin Infect Dis, 45(10): 1290-5. [Abstract] [Full-text]

© 2004-2012 Tuberculosis Research Today. All Rights Reserved.